Loading organizations...
Key people at Summation Health Ventures.
Summation Health Ventures operates as a strategic investment fund, specializing in early to mid-stage healthcare companies. It provides capital and guidance to start-ups developing information technology, technology-enabled devices, and services for the healthcare sector. The firm accelerates the growth of these portfolio companies, helping them deploy their solutions across the healthcare market.
Established in 2014 and based in Los Angeles, Summation Health Ventures emerged from the recognition that entrepreneurial innovation is vital for advancing national healthcare systems. The firm was founded to foster efficiency and progress across healthcare delivery by strategically investing in promising ventures that address systemic needs.
The primary beneficiaries of Summation Health Ventures' work are healthcare systems nationwide, which gain access to advanced solutions from its portfolio. The firm’s vision is to be a driving force in healthcare evolution by continually supporting companies that introduce impactful improvements to patient care, operational efficiency, and technological integration.
Key people at Summation Health Ventures.
Summation Health Ventures has 6 tracked investments across 5 companies. The latest tracked deal is $45.0M Series C in Well Health in November 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 24, 2020 | Well Health | $45.0M Series C | Avery Rosin | Freestyle Capital, Health Velocity Capital, Jackson Square Ventures, Charles N. Martin, Structure Capital |
| Nov 28, 2018 | Prescient Surgical | $10.0M Series B | Baxter Ventures | Eugene Chen, Stanford |
| May 1, 2017 | HealthLoop | $8.0M Series B | — | Bling Capital, Caffeinated Capital, Canvas Ventures, F Prime Capital, Great Oaks Venture Capital, Khosla Ventures, Sequoia Capital, Jeremy Stoppelman, ICarbonX, NextEquity Partners, Ochsner Lafayette General Healthcare |
| Mar 1, 2016 | Gauss Surgical | $13.0M Series B | DAN Galles | Promus Ventures, Garrett Vygantas, M.d., LifeForce Capital, Stanford |
| Aug 1, 2015 | Gauss Surgical | $12.0M Series A | Promus Ventures | LifeForce Capital |
| Mar 13, 2015 | Pager | $10.4M Other Equity | — | Goodwater Capital, LUX Capital, Montage Ventures |
